{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:06:48Z","timestamp":1792699608609,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-03820-3","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T16:59:50Z","timestamp":1745341190000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Remimazolam alleviates hepatic ischemia-reperfusion injury by activating FOXO1\/3 signaling"],"prefix":"10.1186","volume":"25","author":[{"given":"Bo","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"issue":"5","key":"3820_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.jhep.2013.06.017","volume":"59","author":"C Peralta","year":"2013","unstructured":"Peralta C, Jim\u00e9nez-Castro MB, Gracia-Sancho J. Hepatic ischemia and reperfusion injury: effects on the liver sinusoidal milieu. J Hepatol. 2013;59(5):1094\u2013106.","journal-title":"J Hepatol"},{"issue":"23","key":"3820_CR2","doi-asserted-by":"publisher","first-page":"e2007727","DOI":"10.1002\/smll.202007727","volume":"17","author":"Y Guan","year":"2021","unstructured":"Guan Y, et al. Nanotheranostics for the management of hepatic Ischemia-Reperfusion injury. Small. 2021;17(23):e2007727.","journal-title":"Small"},{"issue":"3","key":"3820_CR3","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1007\/s10753-023-01792-8","volume":"46","author":"K Li","year":"2023","unstructured":"Li K, et al. Chlorogenic acid alleviates hepatic Ischemia-Reperfusion injury by inhibiting oxidative stress, inflammation, and Mitochondria-Mediated apoptosis in vivo and in vitro. Inflammation. 2023;46(3):1061\u201376.","journal-title":"Inflammation"},{"key":"3820_CR4","first-page":"p0159","volume":"6","author":"C Zhong","year":"2023","unstructured":"Zhong C, et al. TRPM2 mediates hepatic Ischemia-Reperfusion injury via Ca(2+)-Induced mitochondrial lipid peroxidation through increasing ALOX12 expression. Res (Wash D C). 2023;6:p0159.","journal-title":"Res (Wash D C)"},{"issue":"3","key":"3820_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5114\/fn.2020.100064","volume":"58","author":"W Li","year":"2020","unstructured":"Li W, et al. Overexpression of NLRC3 enhanced Inhibition effect of Sevoflurane on inflammation in an ischaemia reperfusion cell model. Folia Neuropathol. 2020;58(3):213\u201322.","journal-title":"Folia Neuropathol"},{"issue":"3","key":"3820_CR6","doi-asserted-by":"publisher","first-page":"101377","DOI":"10.1016\/j.accpm.2024.101377","volume":"43","author":"C Yang","year":"2024","unstructured":"Yang C, et al. Comparison of the bispectral indices of patients receiving remimazolam and Propofol for general anesthesia: a randomized crossover trial. Anaesth Crit Care Pain Med. 2024;43(3):101377.","journal-title":"Anaesth Crit Care Pain Med"},{"key":"3820_CR7","doi-asserted-by":"publisher","first-page":"690875","DOI":"10.3389\/fphar.2021.690875","volume":"12","author":"GJ Kilpatrick","year":"2021","unstructured":"Kilpatrick GJ. Remimazolam: Non-Clinical and clinical profile of a new sedative\/anesthetic agent. Front Pharmacol. 2021;12:690875.","journal-title":"Front Pharmacol"},{"issue":"6","key":"3820_CR8","first-page":"847","volume":"29","author":"D Shackebaei","year":"2008","unstructured":"Shackebaei D, Godini A, Reshadat S. The effects of diazepam in cardio depressant concentration on the function of isolated rat heart in ischemia-reperfusion. Saudi Med J. 2008;29(6):847\u201353.","journal-title":"Saudi Med J"},{"key":"3820_CR9","doi-asserted-by":"publisher","first-page":"176276","DOI":"10.1016\/j.ejphar.2023.176276","volume":"965","author":"H Xu","year":"2024","unstructured":"Xu H, et al. Remimazolam attenuates myocardial ischemia-reperfusion injury by inhibiting the NF-\u0138B pathway of macrophage inflammation. Eur J Pharmacol. 2024;965:176276.","journal-title":"Eur J Pharmacol"},{"key":"3820_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.2147\/DDDT.S344240","volume":"16","author":"M Shi","year":"2022","unstructured":"Shi M, et al. Protective effects of remimazolam on cerebral ischemia\/reperfusion injury in rats by inhibiting of NLRP3 Inflammasome-Dependent pyroptosis. Drug Des Devel Ther. 2022;16:413\u201323.","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"3820_CR11","doi-asserted-by":"publisher","first-page":"e20285","DOI":"10.1016\/j.heliyon.2023.e20285","volume":"9","author":"W Ding","year":"2023","unstructured":"Ding W, et al. Remimazolam relieved the injury of hypoxia\/reperfusion treated human embryo liver cell line through the targeting METTL3 mediated m6A modification of P53. Heliyon. 2023;9(9):e20285.","journal-title":"Heliyon"},{"issue":"1","key":"3820_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12871-024-02641-3","volume":"24","author":"Y Shi","year":"2024","unstructured":"Shi Y, et al. Remimazolam protects the liver from ischemia-reperfusion injury by inhibiting the MAPK\/ERK pathway. BMC Anesthesiol. 2024;24(1):251.","journal-title":"BMC Anesthesiol"},{"issue":"4","key":"3820_CR13","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrg2523","volume":"10","author":"S Hannenhalli","year":"2009","unstructured":"Hannenhalli S, Kaestner KH. The evolution of Fox genes and their role in development and disease. Nat Rev Genet. 2009;10(4):233\u201340.","journal-title":"Nat Rev Genet"},{"issue":"12","key":"3820_CR14","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.tips.2022.09.010","volume":"43","author":"A Orea-Soufi","year":"2022","unstructured":"Orea-Soufi A, et al. FOXO transcription factors as therapeutic targets in human diseases. Trends Pharmacol Sci. 2022;43(12):1070\u201384.","journal-title":"Trends Pharmacol Sci"},{"issue":"6","key":"3820_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1038\/s41419-023-05879-w","volume":"14","author":"H Ren","year":"2023","unstructured":"Ren H, et al. FOXO1 regulates Th17 cell-mediated hepatocellular carcinoma recurrence after hepatic ischemia-reperfusion injury. Cell Death Dis. 2023;14(6):367.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3820_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41420-020-00347-2","volume":"6","author":"Q Wang","year":"2020","unstructured":"Wang Q, et al. TGR5 deficiency aggravates hepatic ischemic\/reperfusion injury via inhibiting SIRT3\/FOXO3\/HIF-1\u0251 pathway. Cell Death Discov. 2020;6(1):116.","journal-title":"Cell Death Discov"},{"key":"3820_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.trsl.2024.03.006","volume":"272","author":"B Kuang","year":"2024","unstructured":"Kuang B, et al. Genetic and Pharmacological targeting of XBP1 alleviates hepatic ischemia reperfusion injury by enhancing FoxO1-dependent mitophagy. Transl Res. 2024;272:162\u201376.","journal-title":"Transl Res"},{"issue":"4","key":"3820_CR18","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1007\/s10753-021-01416-z","volume":"44","author":"H Ma","year":"2021","unstructured":"Ma H, et al. Propofol protects against hepatic ischemia reperfusion injury via inhibiting Bnip3-Mediated oxidative stress. Inflammation. 2021;44(4):1288\u2013301.","journal-title":"Inflammation"},{"issue":"6","key":"3820_CR19","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1097\/00007890-199306000-00011","volume":"55","author":"S Suzuki","year":"1993","unstructured":"Suzuki S, et al. Neutrophil infiltration as an important factor in liver ischemia and reperfusion injury. Modulating effects of FK506 and cyclosporine. Transplantation. 1993;55(6):1265\u201372.","journal-title":"Transplantation"},{"issue":"2","key":"3820_CR20","doi-asserted-by":"publisher","first-page":"C227","DOI":"10.1152\/ajpcell.00112.2001","volume":"282","author":"C Li","year":"2002","unstructured":"Li C, Jackson RM. Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 2002;282(2):C227\u201341.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"8","key":"3820_CR21","doi-asserted-by":"publisher","first-page":"167496","DOI":"10.1016\/j.bbadis.2024.167496","volume":"1870","author":"H Fang","year":"2024","unstructured":"Fang H, et al. JuA alleviates liver ischemia-reperfusion injury by activating AKT\/NRF2\/HO-1 pathways. Biochim Biophys Acta Mol Basis Dis. 2024;1870(8):167496.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"3820_CR22","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1097\/TP.0000000000004356","volume":"107","author":"K Wu","year":"2023","unstructured":"Wu K, et al. Transcription factor YY1 ameliorates liver Ischemia-reperfusion injury through modulating the miR-181a-5p\/ESR1\/ERBB2 axis. Transplantation. 2023;107(4):878\u201389.","journal-title":"Transplantation"},{"issue":"18","key":"3820_CR23","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1111\/febs.16336","volume":"289","author":"GB R","year":"2022","unstructured":"R GB, et al. Nrf2 and oxidative stress in liver ischemia\/reperfusion injury. Febs J. 2022;289(18):5463\u201379.","journal-title":"Febs J"},{"key":"3820_CR24","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.molmet.2018.09.011","volume":"20","author":"LS Lundell","year":"2019","unstructured":"Lundell LS, et al. Regulation of glucose uptake and inflammation markers by FOXO1 and FOXO3 in skeletal muscle. Mol Metab. 2019;20:79\u201388.","journal-title":"Mol Metab"},{"issue":"8","key":"3820_CR25","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/cdd.2012.13","volume":"19","author":"S Shalini","year":"2012","unstructured":"Shalini S, et al. Impaired antioxidant defence and accumulation of oxidative stress in caspase-2-deficient mice. Cell Death Differ. 2012;19(8):1370\u201380.","journal-title":"Cell Death Differ"},{"key":"3820_CR26","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.3389\/fimmu.2019.02408","volume":"10","author":"H Liu","year":"2019","unstructured":"Liu H, et al. Pterostilbene attenuates astrocytic inflammation and neuronal oxidative injury after Ischemia-Reperfusion by inhibiting NF-\u03baB phosphorylation. Front Immunol. 2019;10:2408.","journal-title":"Front Immunol"},{"issue":"1","key":"3820_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13287-021-02223-x","volume":"12","author":"H Luo","year":"2021","unstructured":"Luo H, et al. METTL3-mediated m(6)A modification regulates cell cycle progression of dental pulp stem cells. Stem Cell Res Ther. 2021;12(1):159.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"3820_CR28","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s40265-020-01299-8","volume":"80","author":"SJ Keam","year":"2020","unstructured":"Keam SJ. Remimazolam: first approval. Drugs. 2020;80(6):625\u201333.","journal-title":"Drugs"},{"issue":"11","key":"3820_CR29","first-page":"3566","volume":"109","author":"MJ Zhao","year":"2023","unstructured":"Zhao MJ, et al. The safety and efficacy between remimazolam and Propofol in intravenous anesthesia of endoscopy operation: a systematic review and meta-analysis. Int J Surg. 2023;109(11):3566\u201377.","journal-title":"Int J Surg"},{"key":"3820_CR30","doi-asserted-by":"publisher","first-page":"110955","DOI":"10.1016\/j.jclinane.2022.110955","volume":"82","author":"JY Choi","year":"2022","unstructured":"Choi JY, et al. Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery: A randomized non-inferiority trial. J Clin Anesth. 2022;82:110955.","journal-title":"J Clin Anesth"},{"key":"3820_CR31","doi-asserted-by":"publisher","first-page":"e15495","DOI":"10.7717\/peerj.15495","volume":"11","author":"Y Chang","year":"2023","unstructured":"Chang Y, et al. Remimazolam versus Propofol for procedural sedation: a meta-analysis of randomized controlled trials. PeerJ. 2023;11:e15495.","journal-title":"PeerJ"},{"issue":"12","key":"3820_CR32","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.23736\/S0375-9393.22.16817-3","volume":"88","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. Remimazolam versus Propofol for procedural sedation and anesthesia: a systemic review and meta-analysis. Minerva Anestesiol. 2022;88(12):1035\u201342.","journal-title":"Minerva Anestesiol"},{"issue":"7","key":"3820_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.4253\/wjge.v16.i7.385","volume":"16","author":"DS Dahiya","year":"2024","unstructured":"Dahiya DS, et al. Remimazolam for sedation in Gastrointestinal endoscopy: A comprehensive review. World J Gastrointest Endosc. 2024;16(7):385\u201395.","journal-title":"World J Gastrointest Endosc"},{"issue":"3","key":"3820_CR34","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s00441-020-03345-z","volume":"384","author":"W Sun","year":"2021","unstructured":"Sun W, et al. Aloin antagonizes stimulated ischemia\/reperfusion-induced damage and inflammatory response in cardiomyocytes by activating the Nrf2\/HO-1 defense pathway. Cell Tissue Res. 2021;384(3):735\u201344.","journal-title":"Cell Tissue Res"},{"issue":"Pt B","key":"3820_CR35","doi-asserted-by":"publisher","first-page":"108331","DOI":"10.1016\/j.intimp.2021.108331","volume":"101","author":"H Fang","year":"2021","unstructured":"Fang H, et al. Remimazolam reduces sepsis-associated acute liver injury by activation of peripheral benzodiazepine receptors and p38 Inhibition of macrophages. Int Immunopharmacol. 2021;101(Pt B):108331.","journal-title":"Int Immunopharmacol"},{"key":"3820_CR36","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/bs.ctdb.2017.10.006","volume":"127","author":"AK Brown","year":"2018","unstructured":"Brown AK, Webb AE. Regulation of FOXO factors in mammalian cells. Curr Top Dev Biol. 2018;127:165\u201392.","journal-title":"Curr Top Dev Biol"},{"issue":"17","key":"3820_CR37","doi-asserted-by":"publisher","first-page":"e2204784","DOI":"10.1002\/advs.202204784","volume":"10","author":"Y Feng","year":"2023","unstructured":"Feng Y, et al. METTL3 mediates Epithelial-Mesenchymal transition by modulating FOXO1 mRNA N(6) -Methyladenosine-Dependent YTHDF2 binding: A novel mechanism of Radiation-Induced lung injury. Adv Sci (Weinh). 2023;10(17):e2204784.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"3820_CR38","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12958-023-01151-0","volume":"21","author":"X Li","year":"2023","unstructured":"Li X, et al. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility. Reprod Biol Endocrinol. 2023;21(1):99.","journal-title":"Reprod Biol Endocrinol"},{"key":"3820_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.molimm.2024.12.001","volume":"177","author":"Z Wang","year":"2025","unstructured":"Wang Z, et al. METTL3\/YTHDF1-mediated m(6)A modification stabilizes USP12 to deubiquitinate FOXO3 and promote apoptosis in sepsis-induced myocardial dysfunction. Mol Immunol. 2025;177:17\u201331.","journal-title":"Mol Immunol"},{"issue":"1","key":"3820_CR40","doi-asserted-by":"publisher","first-page":"25665","DOI":"10.31083\/JIN25665","volume":"24","author":"C Chen","year":"2025","unstructured":"Chen C, Lan L, Xu K. Remimazolam combined with Andrographolide improve postoperative cognitive dysfunction in rats after cardiopulmonary bypass through the AMPK\/SIRT1 signaling pathway. J Integr Neurosci. 2025;24(1):25665.","journal-title":"J Integr Neurosci"},{"issue":"1","key":"3820_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s10020-024-00915-7","volume":"30","author":"X Wei","year":"2024","unstructured":"Wei X, et al. SIRT1-mediated deacetylation of FOXO3 enhances mitophagy and drives hormone resistance in endometrial cancer. Mol Med. 2024;30(1):147.","journal-title":"Mol Med"},{"key":"3820_CR42","doi-asserted-by":"publisher","first-page":"111893","DOI":"10.1016\/j.intimp.2024.111893","volume":"131","author":"M Xu","year":"2024","unstructured":"Xu M, et al. Sirt1 alleviates osteoarthritis via promoting FoxO1 nucleo-cytoplasm shuttling to facilitate autophagy. Int Immunopharmacol. 2024;131:111893.","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"3820_CR43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00018-023-04755-2","volume":"80","author":"M Omorou","year":"2023","unstructured":"Omorou M, et al. The forkhead box O3 (FOXO3): a key player in the regulation of ischemia and reperfusion injury. Cell Mol Life Sci. 2023;80(4):102.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"3820_CR44","first-page":"1138","volume":"10","author":"HZ Ren","year":"2022","unstructured":"Ren HZ, et al. FOXO1 alleviates liver Ischemia-reperfusion injury by regulating the Th17\/Treg ratio through the AKT\/Stat3\/FOXO1 pathway. J Clin Transl Hepatol. 2022;10(6):1138\u201347.","journal-title":"J Clin Transl Hepatol"},{"key":"3820_CR45","doi-asserted-by":"publisher","first-page":"104522","DOI":"10.1016\/j.yexmp.2020.104522","volume":"117","author":"W Lv","year":"2020","unstructured":"Lv W, et al. MiR-302a-3p aggravates myocardial ischemia-reperfusion injury by suppressing mitophagy via targeting FOXO3. Exp Mol Pathol. 2020;117:104522.","journal-title":"Exp Mol Pathol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03820-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-03820-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-03820-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T18:02:42Z","timestamp":1745344962000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-03820-3"}},"subtitle":["Remimazolam alleviates hepatic ischemia reperfusion injury"],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3820"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-03820-3","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"5 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This animal study was approved by the Ethics Committee of Hunan Provincial People\u2019s Hospital (The First Affiliated Hospital of Hunan Normal University), approval number: 2024-(50). All the animal procedures were performed in accordance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"283"}}